Reasons for antibiotic of choice. Logistic regression models predicting likelihood of choosing fluoroquinolone monotherapy and fortified vancomycin, correcting for location.
| Reason | OR | p Value | 95% CI lower bound |
| Fluoroquinolone monotherapy | |||
| Efficacy | 1.05 | 0.91 | 0.45 to 2.46 |
| Coverage | 0.30 | 0.02 | 0.11 to 0.81 |
| Availability | 20.86 | <0.001* | 6.79 to 64.13 |
| Toxicity | 7.48 | <0.001* | 2.53 to 22.09 |
| Synergy | 0.16 | 0.08 | 0.02 to 1.23 |
| Resistance | 0.39 | 0.08 | 0.13 to 1.11 |
| Fortified vancomycin | |||
| Efficacy | 1.96 | 0.06 | 0.97 to 3.92 |
| Coverage | 7.10 | <0.001* | 2.44 to 20.61 |
| Availability | 0.20 | <0.001* | 0.09 to 0.44 |
| Toxicity | 0.10 | 0.003* | 0.02 to 0.45 |
| Synergy | 0.75 | 0.56 | 0.29 to 1.95 |
| Resistance | 12.51 | <0.001* | 4.97 to 31.45 |
*Statistically significant after Holm-Šídák correction for multiple comparisons.